“We want to implement a platform into the world so that medical supplies can be prescribed more easily ”
In the world, the need for regenerative medicine or unmet medical (illnesses for which no cure has been found) is increasing everyday. Chitose is aiming to speed up and reduce costs of the world’s antibiotics manufacturing process by using a super cell to contribute to the global healthcare.
As a leader in the host cell market, we will develop new CHO cells that boast the world's highest production efficiency of antibody drugs, participate in the AMED business, and collaborate with domestic and overseas biopharmaceutical companies.
In order to reduce the price of antibody drugs, which are ever soaring, high efficiency and low manufacturing process costs are required.
Manufacturing Technology Association of Biologics (AMED)